Cefiderocol Production Cost Reports

The report provides a detailed analysis essential for establishing a cefiderocol production plant. It encompasses all critical aspects necessary for cefiderocol production, including the cost of cefiderocol production, cefiderocol plant cost, cefiderocol production costs, and the overall cefiderocol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a cefiderocol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Cefiderocol is a modern antibiotic compound that is mainly used in the healthcare and pharmaceutical industry for treating serious bacterial infections. It is primarily used in hospitals to fight infections caused by drug-resistant Gram-negative bacteria, especially in patients with hospital-acquired pneumonia.

It is mainly used for the treatment of complicated urinary tract infections and hospital-acquired pneumonia caused by aerobic Gram-negative organisms with limited treatment options. It is often used in critical care settings for patients suffering from severe infections in hospitals. It is also used in the management of bloodstream infections and other severe conditions when other antibiotics may not work effectively. Moreover, it is also used as a reference compound in the development of advanced antimicrobial therapies aimed at controlling resistant bacterial strains. It serves as an important medicine in managing life-threatening infections and supporting advanced healthcare treatments.

The market for cefiderocol is primarily driven by its demand as an advanced antibiotic in the treatment of serious bacterial infections that do not respond well to common antibiotics. Its application as an antibiotic in the treatment of complicated urinary tract infections, hospital-acquired pneumonia, and bloodstream infections further drives its demand in the pharmaceutical industry. Its application as a drug for treating serious bacterial infections, especially those caused by drug-resistant gram-negative bacteria, also boosts its demand in the medical and pharmaceutical industries.

Its demand as a medication in modern antimicrobial therapy and antibiotic research for combating multidrug-resistant organisms due to its strong antibacterial action further supports its market growth. Technological advancements in antibiotic production, supplier dependability, cold-chain logistics, and global distribution capacity also impact procurement trends across major markets. Additionally, industrial cefiderocol procurement is influenced by several factors, such as the cost and consistent supply of main active ingredients, strict regulatory approvals, and compliance with safety and environmental standards.

Raw Material for Cefiderocol Production

According to the cefiderocol production plant project report, the major raw materials for cefiderocol production include benzaldehyde, mesyl chloride, aminothiazole, semisynthetic cephalosporin core, sulfuric acid, and p-toluenesulfonic acid.

Production Process of Cefiderocol

The extensive cefiderocol production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of cefiderocol begins with the chlorination of benzaldehyde, followed by demethylation to form catechol. This is protected as a p-methoxybenzyl ether before being oxidised to a benzoic acid derivative. Then, the acid is activated using mesyl chloride and coupled with an amine to produce the protected catechol fragment. In parallel, the β-lactam unit is prepared from aminothiazole and coupled with a semisynthetic cephalosporin core. The resulting intermediate undergoes controlled oxidation to form a sulfoxide, which helps facilitate a major quaternisation reaction with the catechol fragment, forming a key intermediate. The sulfoxide is then reduced back to a sulfide, and the protective PMB groups are removed under acidic conditions. Finally, the process of crystallisation with sulfuric acid and p-toluenesulfonic acid results in the formation of cefiderocol as the desired product.

Cefiderocol is a novel siderophore cephalosporin antibacterial drug that appears as a white to off-white solid powder in its pure form. The molecular formula of the compound is C30H34ClN7O10S2, and its molar mass is 752.21 g/mol. It is commercially marketed under the trade names Fetroja and Fetcroja. The compound has a predicted LogP value of approximately −1.02, which indicates its hydrophilic nature. It is soluble in dimethyl sulfoxide (DMSO) at a maximum concentration of approximately 50 mg/mL but is unstable in solution and should be freshly prepared before use. It is recommended to store the compound at −20 degree Celsius under a nitrogen atmosphere to maintain its stability and protect it from light. The compound is classified as a combustible solid and is contraindicated in patients with a known history of severe hypersensitivity to cefiderocol or other beta-lactam antibacterial drugs. It is recommended to handle the compound with appropriate protective measures, and extended or improper exposure should be avoided to prevent adverse health effects.